Serum hormone levels in women with chronic pain in the Women In Pain Studies, Oxford: a cohort study

niversity of Oxford (UK)0 个研究点目标入组 101 人开始时间: 2015年4月10日最近更新: 2022年1月10日

适应症

试验速览

暂无简介。

•1. Willing and able to give informed consent
•2. Age 18–50
•3. Pelvic or musculoskeletal pain (back, hip or knee or fibromyalgia) for more than 50% of the days per month for at least the past 6 months

•1. Use of exogenous hormones for any reason (including contraception, hormone-replacement therapy and treatment of pain), except women with pelvic pain who may be included if they have a Mirena intrauterine system in place
•2. Use of mild opiates (e.g., codeine phosphate or tramadol) for 50% of the days per month
•3. Use of strong opiates in the past 6 months
•4. Previous hysterectomy or bilateral oophorectomy
•5. Confirmed or suspected pregnancy
•6. Pregnant within the past 6 months or currently breastfeeding
•7. Recreational opiate use in the past 6 months
•8. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant’s ability to participate in the trial

发起方

niversity of Oxford (UK)